Sequent Scientific gains on hike in FII limit
The stock rose 4% at Rs 562 after the RBI said that foreign investors can now invest up to 32.46% of the paid-up capital of the pharmaceutical company.
)
Explore Business Standard
Associate Sponsors
Co-sponsor
The stock rose 4% at Rs 562 after the RBI said that foreign investors can now invest up to 32.46% of the paid-up capital of the pharmaceutical company.
)
First Published: May 15 2015 | 9:21 AM IST